← THE EVIDENCE INDEXThe Study Library.
8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Showing studies that examined oranges & citrus. Clear
An expert overview of the literature, useful as background reading.
2 studies
2010 / Review
This review evaluates metabolic and cardiovascular perspectives related to grapefruit consumption. Grapefruit or grapefruit juice consumption is associated with drug interactions—some fatal—mediated by intestinal CYP3A4, P-glycoprotein, and organic cation transporter proteins. Concurrently, grapefruit's rich flavonoid content has emerged as beneficial in managing degenerative conditions like diabetes and cardiovascular disorders, though the clinical extent of its drug interactions remains not fully determined.
Owira PM, Ojewole JA Cardiovasc J Afr, 2010. PMID 20972517
2006 / Narrative review
This review discusses the management of grapefruit-drug interactions. Grapefruit affects the metabolism of medications that undergo extensive intestinal cytochrome P450 3A4 metabolism, have low bioavailability, or possess a narrow therapeutic index, such as statins, antiarrhythmic agents, immunosuppressants, and calcium channel blockers. Management strategies include substituting equally effective alternative drugs that do not interact with grapefruit or excluding grapefruit from the diet and opting for other fruits, including other types of citrus.
Stump AL, Mayo T, Blum A Am Fam Physician, 2006. PMID 16939181